Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)

NCT07699380 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT07699380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07699380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Recruiting
Start date
September 30, 2026
Completion date
December 31, 2029
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, combination therapy, diabetes melletus, type 1, endocrine system diseases, glucose metabolism disorders, immune system diseases, metabolic diseases, nutritional and metabolic diseases, type 1 diabetes (t1d)